Recombinant Human Epidermal Growth Factor

Therapeutic agent (verify pharmacological class)

📌 1. Dawa Hii Inatumika Kwa Ajili Gani? (What is it for?)

Enhancement of wound healing in such conditions as first and second degree burns, donor site skin grafts and neuropathic diabetic foot ulcers Clinical selection for Recombinant Human Epidermal Growth Factor should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Therapeutic agent (verify pharmacological class). Confirm site-specific dose, duration and monitoring before prescribing.

💊 2. Jinsi Ya Kutumia Dawa Hii (How to take)

Clean the wound, cover the entire area twice daily after 20wks

⚠️ 3. Tahadhari & Madhara Yanayoweza Kutokea (Side Effects & Warnings)

Adverse reactions vary by agent. Counsel on common predictable effects and serious warning symptoms (allergy, severe rash, jaundice, unusual bleeding, severe GI symptoms, neurological changes). Report suspected ADRs via national pharmacovigilance channels.

📦 4. Jinsi Ya Kuhifadhi Dawa (Storage)

Store as labelled. Keep out of reach of children.

Available Branded Equivalents in Kenya

Regen-D Gel (KES 0.00) EPIDERM (KES 48.35)

Provided as a clinical reference by MyDrugIndex Kenya.

Always consult your doctor or registered pharmacist.